KOBO BIOTECH LIMITED (KOBO.BO)
INR 2.9
(4.69%)
INR 2.9
(4.69%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 2.04 Billion INR | 0.49% |
| 2022 | 2.03 Billion INR | 0.84% |
| 2021 | 2.01 Billion INR | -40.31% |
| 2020 | 3.37 Billion INR | 4.16% |
| 2019 | 3.24 Billion INR | 5.84% |
| 2018 | 3.06 Billion INR | 6.23% |
| 2017 | 2.88 Billion INR | 6.51% |
| 2016 | 2.7 Billion INR | 6.6% |
| 2015 | 2.54 Billion INR | 6.67% |
| 2014 | 2.38 Billion INR | 1.59% |
| 2013 | 2.34 Billion INR | -27.6% |
| 2012 | 3.23 Billion INR | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 1.32 Billion INR | -34.94% |
| 2023 FY | 2.04 Billion INR | 0.49% |
| 2023 Q4 | 2.04 Billion INR | 0.0% |
| 2023 Q3 | - INR | -100.0% |
| 2023 Q2 | 2.03 Billion INR | 0.0% |
| 2023 Q1 | - INR | -100.0% |
| 2022 Q2 | 2.02 Billion INR | 0.0% |
| 2022 Q1 | - INR | -100.0% |
| 2022 FY | 2.03 Billion INR | 0.84% |
| 2022 Q4 | 2.03 Billion INR | 0.0% |
| 2022 Q3 | - INR | -100.0% |
| 2021 Q3 | - INR | -100.0% |
| 2021 Q2 | 2.57 Billion INR | 0.0% |
| 2021 Q4 | 2.01 Billion INR | 0.0% |
| 2021 Q1 | - INR | -100.0% |
| 2021 FY | 2.01 Billion INR | -40.31% |
| 2020 Q1 | - INR | -100.0% |
| 2020 Q2 | 3.33 Billion INR | 0.0% |
| 2020 Q4 | 3.37 Billion INR | 0.0% |
| 2020 FY | 3.37 Billion INR | 4.16% |
| 2020 Q3 | - INR | -100.0% |
| 2019 Q3 | - INR | -100.0% |
| 2019 FY | 3.24 Billion INR | 5.84% |
| 2019 Q2 | 3.14 Billion INR | 0.0% |
| 2019 Q4 | 3.24 Billion INR | 0.0% |
| 2019 Q1 | - INR | -100.0% |
| 2018 Q2 | 3.77 Billion INR | 0.0% |
| 2018 Q3 | - INR | -100.0% |
| 2018 Q4 | 3.06 Billion INR | 0.0% |
| 2018 FY | 3.06 Billion INR | 6.23% |
| 2018 Q1 | - INR | -100.0% |
| 2017 Q2 | 2.79 Billion INR | 0.0% |
| 2017 FY | 2.88 Billion INR | 6.51% |
| 2017 Q4 | 2.88 Billion INR | 0.0% |
| 2017 Q3 | - INR | -100.0% |
| 2016 FY | 2.7 Billion INR | 6.6% |
| 2016 Q4 | 2.7 Billion INR | 0.0% |
| 2016 Q3 | - INR | -100.0% |
| 2016 Q2 | 2.62 Billion INR | 0.0% |
| 2016 Q1 | - INR | -100.0% |
| 2015 FY | 2.54 Billion INR | 6.67% |
| 2015 Q3 | - INR | -100.0% |
| 2015 Q4 | 2.54 Billion INR | 0.0% |
| 2015 Q2 | 2.34 Billion INR | 0.0% |
| 2014 FY | 2.38 Billion INR | 1.59% |
| 2014 Q4 | 2.38 Billion INR | 0.0% |
| 2014 Q1 | - INR | 0.0% |
| 2013 FY | 2.34 Billion INR | -27.6% |
| 2012 FY | 3.23 Billion INR | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| DECIPHER LABS LIMITED | 117.72 Million INR | -1635.433% |
| Gujarat Themis Biosyn Limited | 197.37 Million INR | -935.115% |
| Ishita Drugs and Industries Limited | 8.87 Million INR | -22927.931% |
| MedPlus Health Services Limited | 14.27 Billion INR | 85.687% |
| ANG Lifesciences India Limited | 1.66 Billion INR | -22.956% |
| Add-Shop E-Retail Limited | 159.2 Million INR | -1183.283% |
| Bacil Pharma Limited | 1.12 Million INR | -180859.965% |
| BDH Industries Limited | 312.53 Million INR | -553.699% |
| Beryl Drugs Limited | 85.63 Million INR | -2285.723% |
| Cian Healthcare Limited | 1.03 Billion INR | -97.519% |
| Chemo Pharma Laboratories Limited | 2.12 Million INR | -95907.425% |
| Concord Drugs Limited | 249.88 Million INR | -717.588% |
| Deccan Health Care Limited | 111.33 Million INR | -1735.02% |
| Gujarat Terce Laboratories Limited | 161.67 Million INR | -1163.678% |
| Hindustan Bio Sciences Limited | 25.7 Million INR | -7849.234% |
| Jenburkt Pharmaceuticals Limited | 201.59 Million INR | -913.452% |
| KIMIA BIOSCIENCES LIMITED | 996.35 Million INR | -105.051% |
| Kwality Pharmaceuticals Limited | 1.71 Billion INR | -19.04% |
| Makers Laboratories Limited | 569.18 Million INR | -258.944% |
| Medi-Caps Limited | 63.01 Million INR | -3142.094% |
| Panchsheel Organics Limited | 340.2 Million INR | -500.537% |
| Parmax Pharma Limited | 117.56 Million INR | -1637.754% |
| Parnax Lab Limited | 1.17 Billion INR | -74.512% |
| Patidar Buildcon Limited | 25.57 Million INR | -7889.356% |
| Phaarmasia Limited | 211.49 Million INR | -865.998% |
| Vikram Thermo (India) Limited | 291.47 Million INR | -600.928% |
| Sanjivani Paranteral Limited. | 155.06 Million INR | -1217.537% |
| SHAMROCK INDUSTRIAL CO.LTD. | 299 Thousand INR | -683190.301% |
| Smruthi Organics Limited | 485.72 Million INR | -320.621% |
| Source Natural Foods and Herbal Supplements Limited | 41.97 Million INR | -4767.621% |
| SUDARSHAN PHARMA INDUSTRIES LI | 1.71 Billion INR | -19.184% |
| Trident Lifeline Limited | 331.26 Million INR | -516.744% |
| Transchem Limited | 6.72 Million INR | -30302.351% |
| Trinity League India Limited | 876 Thousand INR | -233123.516% |
| Tyche Industries Limited | 101.64 Million INR | -1910.053% |
| Vista Pharmaceuticals Limited | 175.16 Million INR | -1066.337% |
| Vivanza Biosciences Limited | 148.63 Million INR | -1274.571% |
| PRAVEG LIMITED | 767.53 Million INR | -166.182% |
| Sastasundar Ventures Limited | 1.5 Billion INR | -36.149% |
| Sunil Healthcare Limited | 902.83 Million INR | -126.292% |
| Syschem (India) Limited | 1.07 Billion INR | -90.81% |
| Zenith Healthcare Limited | 24.03 Million INR | -8400.262% |
| Zenlabs Ethica Limited | 301.35 Million INR | -577.953% |
| Mercury Laboratories Limited | 171.18 Million INR | -1093.44% |
| SHELTER PHARMA LIMITED | 20.99 Million INR | -9633.387% |
| Vasundhara Rasayans Limited | 53.64 Million INR | -3708.299% |
| Bharat Immunologicals & Biologicals Corporation Limited | 1 Billion INR | -103.423% |
| Roopa Industries Limited | 493.08 Million INR | -314.336% |
| PANJON LTD. | 25.38 Million INR | -7948.844% |
| Pharmaids Pharmaceuticals Limited | 208.44 Million INR | -880.152% |
| TIAAN CONSUMER LIMITED | 14.97 Million INR | -13539.348% |
| Anuh Pharma Limited | 1.54 Billion INR | -32.268% |
| Crestchem Limited | 23.94 Million INR | -8431.499% |
| Emmessar Biotech & Nutrition Limited | 13.4 Million INR | -15140.865% |
| Sandu Pharmaceuticals Limited | 118.22 Million INR | -1628.122% |
| Fredun Pharmaceuticals Limited | 1.86 Billion INR | -9.765% |
| Trimurthi Limited | 101.36 Thousand INR | -2015525.493% |
| Shukra Pharmaceuticals Limited | 201.97 Million INR | -911.535% |
| Norris Medicines Limited | 278.17 Million INR | -634.448% |
| Veerhealth Care Limited | 62.78 Million INR | -3154.282% |
| Lactose (India) Limited | 536.39 Million INR | -280.882% |
| OXYGENTA PHARMACEUTICAL LIMITE | 833.14 Million INR | -145.22% |
| Ambalal Sarabhai Enterprises Limited | 1.13 Billion INR | -80.656% |
| Gennex Laboratories Limited | 535.21 Million INR | -281.725% |
| Denis Chem Lab Limited | 289.82 Million INR | -604.929% |
| Colinz Laboratories Limited | 24.1 Million INR | -8375.578% |
| Godavari Drugs Limited | 957.86 Million INR | -113.291% |
| Zenotech Laboratories Limited | 156.64 Million INR | -1204.222% |
| Shree Ganesh Remedies Limited | 488.36 Million INR | -318.34% |
| Bharat Parenterals Limited | 2.65 Billion INR | 23.092% |
| Coral Laboratories Limited | 281.83 Million INR | -624.895% |
| Evoq Remedies Limited | 116.23 Million INR | -1657.724% |
| Kerala Ayurveda Limited | 1.05 Billion INR | -93.168% |
| Natural Capsules Limited | 1.47 Billion INR | -38.304% |
| Auro Laboratories Limited | 433.09 Million INR | -371.728% |